+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neurology Devices Market by Product, End-user: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 220 Pages
  • February 2023
  • Region: Global
  • Allied Market Research
  • ID: 5781723
Description Jump to:
The neurology devices market was valued at $12.6 billion in 2021 and is estimated to reach $27.2 billion by 2031, exhibiting a CAGR of 8.1% from 2022 to 2031.

Neurology is a branch of medicine that deals with the study, diagnosis, and treatment of disorders and diseases that affect the nervous system. The nervous system is a complex network of cells, tissues, and organs that coordinate and regulate the body's activities. It includes the brain, spinal cord, and nerves throughout the body. Neurology devices are medical instruments and equipment that are used to diagnose and treat of neurological conditions.

One of the major factors driving the growth of the neurology devices market include aging population, The rise in the geriatric population is having a significant impact on the neurology device market. As people age, they become more susceptible to neurological disorders, such as Alzheimer's disease, Parkinson's disease, and stroke. For instance, according to Alzheimer's Association the percentage of people with Alzheimer’s disease increases significantly with age: 5.0% of people age 65 to 74, 13.1% of people age 75 to 84 and 33.2% of people age 85 or older have Alzheimer’s disease. In addition, the geriatric population tends to have higher healthcare needs and spends more on healthcare services.

Furthermore, surge in preference for non-invasive and minimally invasive treatments, increase in healthcare spending, technological advancements, and rise in patient adoption is fueling market growth. Surge in prevalence of neurological disorders has been a significant driving force in the neurology device market. For instance, neurological disorders such as Alzheimer's and Parkinson's disease are more common in older people, and the number of people with these conditions is expected to rise as the population ages. Furthermore, the rise in acceptance of minimally invasive treatments as an alternative to traditional surgery is a major driver of the neurology devices market. The increase in spending on healthcare is driving the demand for neurology devices.

Technological convergence in neurological devices is a rapidly evolving field that is revolutionizing the way neurological conditions are diagnosed, treated, and managed. Compact size and wireless technology advances. Robotics and artificial intelligence are being integrated into neurological devices to improve their accuracy, speed, and functionality.

However, factors such as the high cost of neurology treatment, lack of skilled professionals, and stringent regulatory frameworks might restrain the growth of the neurology device market.

The neurological device market is segmented into product type, end user and region. By product type, the market is categorized into neurostimulation devices, neurosurgery devices, interventional neurology devices, cerebrospinal fluid management devices and others. On the basis of end user, the market is categorized into hospitals, ambulatory surgery centers, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global neurology device market are Integra Lifesciences, B.Braun SE, Medtronic plc, Natus Medical Inc, Stryker Corporation, Boston Scientific Corporation, Abbott Laboratories, LivaNova PLC, Zimmer Biomet Holding Inc. and Johnson & Johnson.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the neurology devices market analysis from 2021 to 2031 to identify the prevailing neurology devices market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the neurology devices market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global neurology devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Neurostimulation Devices
  • Device type
  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators
  • Others
  • Neurosurgery Devices
  • Device type
  • Neuroendoscopy
  • neurosurgery navigations
  • Interventional Neurology Devices
  • Device type
  • Embolization Devices
  • Revascularization Devices
  • Thrombectomy Devices
  • Embolic Protection Devices
  • Accessory Devices
  • Cerebrospinal fluid management devices
  • Device type
  • CSF shunts
  • External drainage system
  • Others

By End User

  • Hospitals
  • Ambulatory surgery centers
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Zimmer Biomet Holding Inc.
  • Johnson & Johnson
  • Stryker Corporation
  • LivaNova PLC
  • B.Braun SE
  • Integra Lifesciences
  • Natus Medical Inc.

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Aging population
3.4.1.2. Surge in demand for non-invasive and minimally invasive treatments
3.4.1.3. Initiatives by government and non-government organizations
3.4.1.4. Increase in prevalence of neurological disorders
3.4.2. Restraints
3.4.2.1. High cost of neurology devices
3.4.2.2. Lack of skilled professionals
3.4.2.3. Stringent regulatory frameworks
3.4.3. Opportunities
3.4.3.1. Technological advancement
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: NEUROLOGY DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Neurostimulation Devices
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Neurostimulation Devices Neurology Devices Market by Device type
4.2.4.1. Spinal Cord Stimulators Market size and forecast, by region
4.2.4.2. Deep Brain Stimulators Market size and forecast, by region
4.2.4.3. Sacral Nerve Stimulators Market size and forecast, by region
4.2.4.4. Vagus Nerve Stimulators Market size and forecast, by region
4.2.4.5. Others Market size and forecast, by region
4.3. Neurosurgery Devices
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Neurosurgery Devices Neurology Devices Market by Device type
4.3.4.1. Neuroendoscopy Market size and forecast, by region
4.3.4.2. neurosurgery navigations Market size and forecast, by region
4.4. Interventional Neurology Devices
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.4.4. Interventional Neurology Devices Neurology Devices Market by Device type
4.4.4.1. Embolization Devices Market size and forecast, by region
4.4.4.2. Revascularization Devices Market size and forecast, by region
4.4.4.3. Thrombectomy Devices Market size and forecast, by region
4.4.4.4. Embolic Protection Devices Market size and forecast, by region
4.4.4.5. Accessory Devices Market size and forecast, by region
4.5. Cerebrospinal fluid management devices
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.5.4. Cerebrospinal fluid management devices Neurology Devices Market by Device type
4.5.4.1. CSF shunts Market size and forecast, by region
4.5.4.2. External drainage system Market size and forecast, by region
4.6. Others
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
CHAPTER 5: NEUROLOGY DEVICES MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Ambulatory surgery centers
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Others
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: NEUROLOGY DEVICES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key trends and opportunities
6.2.2. Market size and forecast, by Product
6.2.2.1. North America Neurostimulation Devices Neurology Devices Market by Device type
6.2.2.2. North America Neurosurgery Devices Neurology Devices Market by Device type
6.2.2.3. North America Interventional Neurology Devices Neurology Devices Market by Device type
6.2.2.4. North America Cerebrospinal fluid management devices Neurology Devices Market by Device type
6.2.3. Market size and forecast, by End User
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Key market trends, growth factors and opportunities
6.2.4.1.2. Market size and forecast, by Product
6.2.4.1.3. Market size and forecast, by End User
6.2.4.2. Canada
6.2.4.2.1. Key market trends, growth factors and opportunities
6.2.4.2.2. Market size and forecast, by Product
6.2.4.2.3. Market size and forecast, by End User
6.2.4.3. Mexico
6.2.4.3.1. Key market trends, growth factors and opportunities
6.2.4.3.2. Market size and forecast, by Product
6.2.4.3.3. Market size and forecast, by End User
6.3. Europe
6.3.1. Key trends and opportunities
6.3.2. Market size and forecast, by Product
6.3.2.1. Europe Neurostimulation Devices Neurology Devices Market by Device type
6.3.2.2. Europe Neurosurgery Devices Neurology Devices Market by Device type
6.3.2.3. Europe Interventional Neurology Devices Neurology Devices Market by Device type
6.3.2.4. Europe Cerebrospinal fluid management devices Neurology Devices Market by Device type
6.3.3. Market size and forecast, by End User
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Key market trends, growth factors and opportunities
6.3.4.1.2. Market size and forecast, by Product
6.3.4.1.3. Market size and forecast, by End User
6.3.4.2. France
6.3.4.2.1. Key market trends, growth factors and opportunities
6.3.4.2.2. Market size and forecast, by Product
6.3.4.2.3. Market size and forecast, by End User
6.3.4.3. UK
6.3.4.3.1. Key market trends, growth factors and opportunities
6.3.4.3.2. Market size and forecast, by Product
6.3.4.3.3. Market size and forecast, by End User
6.3.4.4. Italy
6.3.4.4.1. Key market trends, growth factors and opportunities
6.3.4.4.2. Market size and forecast, by Product
6.3.4.4.3. Market size and forecast, by End User
6.3.4.5. Spain
6.3.4.5.1. Key market trends, growth factors and opportunities
6.3.4.5.2. Market size and forecast, by Product
6.3.4.5.3. Market size and forecast, by End User
6.3.4.6. Rest of Europe
6.3.4.6.1. Key market trends, growth factors and opportunities
6.3.4.6.2. Market size and forecast, by Product
6.3.4.6.3. Market size and forecast, by End User
6.4. Asia-Pacific
6.4.1. Key trends and opportunities
6.4.2. Market size and forecast, by Product
6.4.2.1. Asia-Pacific Neurostimulation Devices Neurology Devices Market by Device type
6.4.2.2. Asia-Pacific Neurosurgery Devices Neurology Devices Market by Device type
6.4.2.3. Asia-Pacific Interventional Neurology Devices Neurology Devices Market by Device type
6.4.2.4. Asia-Pacific Cerebrospinal fluid management devices Neurology Devices Market by Device type
6.4.3. Market size and forecast, by End User
6.4.4. Market size and forecast, by country
6.4.4.1. China
6.4.4.1.1. Key market trends, growth factors and opportunities
6.4.4.1.2. Market size and forecast, by Product
6.4.4.1.3. Market size and forecast, by End User
6.4.4.2. Japan
6.4.4.2.1. Key market trends, growth factors and opportunities
6.4.4.2.2. Market size and forecast, by Product
6.4.4.2.3. Market size and forecast, by End User
6.4.4.3. India
6.4.4.3.1. Key market trends, growth factors and opportunities
6.4.4.3.2. Market size and forecast, by Product
6.4.4.3.3. Market size and forecast, by End User
6.4.4.4. Australia
6.4.4.4.1. Key market trends, growth factors and opportunities
6.4.4.4.2. Market size and forecast, by Product
6.4.4.4.3. Market size and forecast, by End User
6.4.4.5. South Korea
6.4.4.5.1. Key market trends, growth factors and opportunities
6.4.4.5.2. Market size and forecast, by Product
6.4.4.5.3. Market size and forecast, by End User
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Key market trends, growth factors and opportunities
6.4.4.6.2. Market size and forecast, by Product
6.4.4.6.3. Market size and forecast, by End User
6.5. LAMEA
6.5.1. Key trends and opportunities
6.5.2. Market size and forecast, by Product
6.5.2.1. LAMEA Neurostimulation Devices Neurology Devices Market by Device type
6.5.2.2. LAMEA Neurosurgery Devices Neurology Devices Market by Device type
6.5.2.3. LAMEA Interventional Neurology Devices Neurology Devices Market by Device type
6.5.2.4. LAMEA Cerebrospinal fluid management devices Neurology Devices Market by Device type
6.5.3. Market size and forecast, by End User
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Key market trends, growth factors and opportunities
6.5.4.1.2. Market size and forecast, by Product
6.5.4.1.3. Market size and forecast, by End User
6.5.4.2. Saudi Arabia
6.5.4.2.1. Key market trends, growth factors and opportunities
6.5.4.2.2. Market size and forecast, by Product
6.5.4.2.3. Market size and forecast, by End User
6.5.4.3. South Africa
6.5.4.3.1. Key market trends, growth factors and opportunities
6.5.4.3.2. Market size and forecast, by Product
6.5.4.3.3. Market size and forecast, by End User
6.5.4.4. Rest of LAMEA
6.5.4.4.1. Key market trends, growth factors and opportunities
6.5.4.4.2. Market size and forecast, by Product
6.5.4.4.3. Market size and forecast, by End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2021
CHAPTER 8: COMPANY PROFILES
8.1. Integra Lifesciences
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. B.Braun SE
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.3. Medtronic plc
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.3.7. Key strategic moves and developments
8.4. Natus Medical Inc.
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Key strategic moves and developments
8.5. Stryker Corporation
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. Boston Scientific Corporation
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. Abbott Laboratories
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.7.7. Key strategic moves and developments
8.8. LivaNova PLC
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.8.7. Key strategic moves and developments
8.9. Zimmer Biomet Holding Inc.
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.9.7. Key strategic moves and developments
8.10. Johnson & Johnson
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance
List of Tables
TABLE 01. GLOBAL NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 02. NEUROLOGY DEVICES MARKET FOR NEUROSTIMULATION DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 03. GLOBAL NEUROSTIMULATION DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 04. NEUROLOGY DEVICES MARKET FOR SPINAL CORD STIMULATORS, BY REGION, 2021-2031 ($MILLION)
TABLE 05. NEUROLOGY DEVICES MARKET FOR DEEP BRAIN STIMULATORS, BY REGION, 2021-2031 ($MILLION)
TABLE 06. NEUROLOGY DEVICES MARKET FOR SACRAL NERVE STIMULATORS, BY REGION, 2021-2031 ($MILLION)
TABLE 07. NEUROLOGY DEVICES MARKET FOR VAGUS NERVE STIMULATORS, BY REGION, 2021-2031 ($MILLION)
TABLE 08. NEUROLOGY DEVICES MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 09. NEUROLOGY DEVICES MARKET FOR NEUROSURGERY DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 10. GLOBAL NEUROSURGERY DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 11. NEUROLOGY DEVICES MARKET FOR NEUROENDOSCOPY, BY REGION, 2021-2031 ($MILLION)
TABLE 12. NEUROLOGY DEVICES MARKET FOR NEUROSURGERY NAVIGATIONS, BY REGION, 2021-2031 ($MILLION)
TABLE 13. NEUROLOGY DEVICES MARKET FOR INTERVENTIONAL NEUROLOGY DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 14. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 15. NEUROLOGY DEVICES MARKET FOR EMBOLIZATION DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 16. NEUROLOGY DEVICES MARKET FOR REVASCULARIZATION DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 17. NEUROLOGY DEVICES MARKET FOR THROMBECTOMY DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 18. NEUROLOGY DEVICES MARKET FOR EMBOLIC PROTECTION DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 19. NEUROLOGY DEVICES MARKET FOR ACCESSORY DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 20. NEUROLOGY DEVICES MARKET FOR CEREBROSPINAL FLUID MANAGEMENT DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 21. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 22. NEUROLOGY DEVICES MARKET FOR CSF SHUNTS, BY REGION, 2021-2031 ($MILLION)
TABLE 23. NEUROLOGY DEVICES MARKET FOR EXTERNAL DRAINAGE SYSTEM, BY REGION, 2021-2031 ($MILLION)
TABLE 24. NEUROLOGY DEVICES MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 25. GLOBAL NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 26. NEUROLOGY DEVICES MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 27. NEUROLOGY DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2021-2031 ($MILLION)
TABLE 28. NEUROLOGY DEVICES MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 29. NEUROLOGY DEVICES MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 30. NORTH AMERICA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 31. NORTH AMERICA NEUROSTIMULATION DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 32. NORTH AMERICA NEUROSURGERY DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 33. NORTH AMERICA INTERVENTIONAL NEUROLOGY DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 34. NORTH AMERICA CEREBROSPINAL FLUID MANAGEMENT DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 35. NORTH AMERICA NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 36. NORTH AMERICA NEUROLOGY DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 37. U.S. NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 38. U.S. NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 39. CANADA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 40. CANADA NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 41. MEXICO NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 42. MEXICO NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 43. EUROPE NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 44. EUROPE NEUROSTIMULATION DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 45. EUROPE NEUROSURGERY DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 46. EUROPE INTERVENTIONAL NEUROLOGY DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 47. EUROPE CEREBROSPINAL FLUID MANAGEMENT DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 48. EUROPE NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 49. EUROPE NEUROLOGY DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 50. GERMANY NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 51. GERMANY NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 52. FRANCE NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 53. FRANCE NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 54. UK NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 55. UK NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 56. ITALY NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 57. ITALY NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 58. SPAIN NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 59. SPAIN NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 60. REST OF EUROPE NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 61. REST OF EUROPE NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 62. ASIA-PACIFIC NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 63. ASIA-PACIFIC NEUROSTIMULATION DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 64. ASIA-PACIFIC NEUROSURGERY DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 65. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 66. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 67. ASIA-PACIFIC NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 68. ASIA-PACIFIC NEUROLOGY DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 69. CHINA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 70. CHINA NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 71. JAPAN NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 72. JAPAN NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 73. INDIA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 74. INDIA NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 75. AUSTRALIA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 76. AUSTRALIA NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 77. SOUTH KOREA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 78. SOUTH KOREA NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 79. REST OF ASIA-PACIFIC NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 80. REST OF ASIA-PACIFIC NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 81. LAMEA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 82. LAMEA NEUROSTIMULATION DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 83. LAMEA NEUROSURGERY DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 84. LAMEA INTERVENTIONAL NEUROLOGY DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 85. LAMEA CEREBROSPINAL FLUID MANAGEMENT DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 86. LAMEA NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 87. LAMEA NEUROLOGY DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 88. BRAZIL NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 89. BRAZIL NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 90. SAUDI ARABIA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 91. SAUDI ARABIA NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 92. SOUTH AFRICA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 93. SOUTH AFRICA NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 94. REST OF LAMEA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 95. REST OF LAMEA NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 96. INTEGRA LIFESCIENCES: KEY EXECUTIVES
TABLE 97. INTEGRA LIFESCIENCES: COMPANY SNAPSHOT
TABLE 98. INTEGRA LIFESCIENCES: PRODUCT SEGMENTS
TABLE 99. INTEGRA LIFESCIENCES: PRODUCT PORTFOLIO
TABLE 100. INTEGRA LIFESCIENCES: KEY STRATERGIES
TABLE 101. B. BRAUN SE: KEY EXECUTIVES
TABLE 102. B. BRAUN SE: COMPANY SNAPSHOT
TABLE 103. B. BRAUN SE: PRODUCT SEGMENTS
TABLE 104. B. BRAUN SE: PRODUCT PORTFOLIO
TABLE 105. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 106. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 107. MEDTRONIC PLC: PRODUCT SEGMENTS
TABLE 108. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 109. MEDTRONIC PLC: KEY STRATERGIES
TABLE 110. NATUS MEDICAL INC.: KEY EXECUTIVES
TABLE 111. NATUS MEDICAL INC.: COMPANY SNAPSHOT
TABLE 112. NATUS MEDICAL INC.: SERVICE SEGMENTS
TABLE 113. NATUS MEDICAL INC.: PRODUCT PORTFOLIO
TABLE 114. NATUS MEDICAL INC.: KEY STRATERGIES
TABLE 115. STRYKER CORPORATION: KEY EXECUTIVES
TABLE 116. STRYKER CORPORATION: COMPANY SNAPSHOT
TABLE 117. STRYKER CORPORATION: PRODUCT SEGMENTS
TABLE 118. STRYKER CORPORATION: PRODUCT PORTFOLIO
TABLE 119. STRYKER CORPORATION: KEY STRATERGIES
TABLE 120. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 121. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 122. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
TABLE 123. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 124. BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 125. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 126. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 127. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 128. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 129. ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 130. LIVANOVA PLC: KEY EXECUTIVES
TABLE 131. LIVANOVA PLC: COMPANY SNAPSHOT
TABLE 132. LIVANOVA PLC: PRODUCT SEGMENTS
TABLE 133. LIVANOVA PLC: PRODUCT PORTFOLIO
TABLE 134. LIVANOVA PLC: KEY STRATERGIES
TABLE 135. ZIMMER BIOMET HOLDING INC.: KEY EXECUTIVES
TABLE 136. ZIMMER BIOMET HOLDING INC.: COMPANY SNAPSHOT
TABLE 137. ZIMMER BIOMET HOLDING INC.: PRODUCT SEGMENTS
TABLE 138. ZIMMER BIOMET HOLDING INC.: PRODUCT PORTFOLIO
TABLE 139. ZIMMER BIOMET HOLDING INC.: KEY STRATERGIES
TABLE 140. JOHNSON & JOHNSON: KEY EXECUTIVES
TABLE 141. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 142. JOHNSON & JOHNSON: PRODUCT SEGMENTS
TABLE 143. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
List of Figures
FIGURE 01. NEUROLOGY DEVICES MARKET, 2021-2031
FIGURE 02. SEGMENTATION OF NEUROLOGY DEVICES MARKET, 2021-2031
FIGURE 03. TOP INVESTMENT POCKETS IN NEUROLOGY DEVICES MARKET (2022-2031)
FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05. LOW BARGAINING POWER OF BUYERS
FIGURE 06. LOW THREAT OF SUBSTITUTES
FIGURE 07. LOW THREAT OF NEW ENTRANTS
FIGURE 08. LOW INTENSITY OF RIVALRY
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALNEUROLOGY DEVICES MARKET
FIGURE 10. NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF NEUROLOGY DEVICES MARKET FOR NEUROSTIMULATION DEVICES, BY COUNTRY 2021-2031 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF NEUROLOGY DEVICES MARKET FOR NEUROSURGERY DEVICES, BY COUNTRY 2021-2031 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF NEUROLOGY DEVICES MARKET FOR INTERVENTIONAL NEUROLOGY DEVICES, BY COUNTRY 2021-2031 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF NEUROLOGY DEVICES MARKET FOR CEREBROSPINAL FLUID MANAGEMENT DEVICES, BY COUNTRY 2021-2031 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF NEUROLOGY DEVICES MARKET FOR OTHERS, BY COUNTRY 2021-2031 (%)
FIGURE 16. NEUROLOGY DEVICES MARKET, BY END USER, 2021 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF NEUROLOGY DEVICES MARKET FOR HOSPITALS, BY COUNTRY 2021-2031 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF NEUROLOGY DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY 2021-2031 (%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF NEUROLOGY DEVICES MARKET FOR OTHERS, BY COUNTRY 2021-2031 (%)
FIGURE 20. NEUROLOGY DEVICES MARKET BY REGION, 2021
FIGURE 21. U.S. NEUROLOGY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 22. CANADA NEUROLOGY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 23. MEXICO NEUROLOGY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 24. GERMANY NEUROLOGY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 25. FRANCE NEUROLOGY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 26. UK NEUROLOGY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 27. ITALY NEUROLOGY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 28. SPAIN NEUROLOGY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 29. REST OF EUROPE NEUROLOGY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 30. CHINA NEUROLOGY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 31. JAPAN NEUROLOGY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 32. INDIA NEUROLOGY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 33. AUSTRALIA NEUROLOGY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 34. SOUTH KOREA NEUROLOGY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 35. REST OF ASIA-PACIFIC NEUROLOGY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 36. BRAZIL NEUROLOGY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 37. SAUDI ARABIA NEUROLOGY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 38. SOUTH AFRICA NEUROLOGY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 39. REST OF LAMEA NEUROLOGY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 44. COMPETITIVE DASHBOARD
FIGURE 45. COMPETITIVE HEATMAP: NEUROLOGY DEVICES MARKET
FIGURE 46. TOP PLAYER POSITIONING, 2021
FIGURE 47. INTEGRA LIFESCIENCES: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 48. INTEGRA LIFESCIENCES: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 49. INTEGRA LIFESCIENCES: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 50. B. BRAUN SE: NET SALES, 2019-2021 ($MILLION)
FIGURE 51. B. BRAUN SE: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 52. B. BRAUN SE: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 53. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
FIGURE 54. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 55. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 56. STRYKER CORPORATION: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 57. STRYKER CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 58. STRYKER CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 59. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2019-2021 ($MILLION)
FIGURE 60. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 61. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 62. ABBOTT LABORATORIES: NET SALES, 2019-2021 ($MILLION)
FIGURE 63. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 64. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 65. LIVANOVA PLC: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 66. LIVANOVA PLC: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 67. LIVANOVA PLC: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 68. ZIMMER BIOMET HOLDING INC.: NET SALES, 2019-2021 ($MILLION)
FIGURE 69. ZIMMER BIOMET HOLDING INC.: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 70. ZIMMER BIOMET HOLDING INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 71. JOHNSON & JOHNSON: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 72. JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 73. JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2021 (%)

Executive Summary

According to the report titled, “Neurology Devices Market," the neurology devices market was valued at $12.6 billion in 2021, and is estimated to reach $27.2 billion by 2031, growing at a CAGR of 8.1% from 2022 to 2031.

Neurology is the branch of medicine that deals with nervous system disorders. It puts emphasis on the diagnosis, treatment, and management of conditions affecting the brain, spinal cord, nerves, and muscles. The neurology device market includes medical equipment and technologies used to diagnose, treat, and monitor neurological disorders such as Alzheimer's disease, tumors, and Parkinson's disease.

Key factors driving the growth of the neurology devices market are aging population, surge in demand for non-invasive and minimally invasive treatments and increase in prevalence of neurological disorders. The prevalence of neurological disorders appears to be increasing in recent years, possibly due to a combination of factors, including changes in lifestyle and environmental factors, improved diagnosis, and an aging population. For instance, according to article published by WHO currently more than 55 million people live with dementia worldwide, and there are nearly 10 million new cases every year. Furthermore, dementia results from a variety of diseases and injuries that primarily or secondarily affect the brain. Alzheimer's disease is the most common form of dementia and may contribute to 60-70% of cases., resulting in demand of neurological devices, thereby is anticipated to contribute to growth of market.

Moreover, non-invasive treatments refer to those that do not require any incisions or injections and can be performed on the surface of the skin, such as topical creams or laser treatments. Minimally invasive treatments, on the other hand, involve small incisions or injections and are typically performed with the aid of imaging technologies or other advanced tools, such as endoscopes or catheters. For instance, , according to a study performed by the National Library of Medicine, the preference of patients toward minimally invasive treatments has raised by 36% over the last 16 years. In addition, increase in availability of new technologies that allow for more precise and effective treatments with fewer side effects.

Further, the aging population is one of the factors driving the growth of the neurology devices market. As people age, the risk of developing neurological disorders such as Alzheimer's disease, Parkinson's disease, and stroke increases. For instance, according to Alzheimer's Association the percentage of people with Alzheimer’s disease increases dramatically with age: 5.0% of people age 65 to 74, 13.1% of people age 75 to 84 and 33.2% of people age 85 or older have Alzheimer’s disease. Furthermore, according to a study by Parkinson’s Foundation in 2022 nearly 90,000 people are diagnosed with Parkinson’s disease in the U.S. each year. This represents a steep 50% increase from the previously estimated rate of 60,000 diagnoses annually and the study confirmed that number of people diagnosed with PD increases with age.

The market also offers growth opportunities to the key players in the market. Many developing regions such India and Brazil offer lucrative opportunities to key players of neurology devices market owing to high population base, increase in demand of neurology devices for disease diagnosis and increase in healthcare spending.

The neurology device market is segmented on the basis of product, end user and region. By product, the market is classified into neurostimulation devices neurosurgery devices, interventional neurology devices, cerebrospinal fluid management devices and others. By end user, it is fragmented into hospitals, ambulatory surgery centers and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global neurology device market are Integra Lifesciences, B.Braun SE, Medtronic plc, Natus Medical Inc, Stryker Corporation, Boston Scientific Corporation, Abbott Laboratories, LivaNova PLC, Zimmer Biomet Holding Inc. and Johnson & Johnson. The players in the market have been actively engaged in the adoption various strategies such product launch, product approval, product development acquisition to remain competitive and gain advantage over the competitors in the market. For instance, In Oct. 30, 2019 Medtronic plc announced the U.S. launch of its advanced Patient Programmer technology for Deep Brain Stimulation (DBS) therapy at the Samsung Developers Conference in San Jose, Calif.

Key Market Insights

  • By type, the Interventional Neurology Devices segment was highest contributor to the market in 2021. However, Neurosurgery Devices segment is anticipated to grow at the highest CAGR during the forecast period.
  • By end user, the Hospitals segment dominated the market in terms of revenue in 2021. However, the Ambulatory surgery centers segment is anticipated to grow at the highest CAGR during the forecast period.
  • Region wise, North America generated the largest revenue in 2021. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period

Companies Mentioned

  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Zimmer Biomet Holding Inc.
  • Johnson & Johnson
  • Stryker Corporation
  • LivaNova PLC
  • B.Braun SE
  • Integra Lifesciences
  • Natus Medical Inc.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Related Topics

Related Reports

Neurology Devices Market 2024 Edition: Market Size, Trends, Opportunities and Forecast by Product Type, Treatment Stage, End-Users, Region, By Country: 2020-2030 - Product Image

Neurology Devices Market 2024 Edition: Market Size, Trends, Opportunities and Forecast by Product Type, Treatment Stage, End-Users, Region, By Country: 2020-2030

  • Report
  • 310 Pages
  • Global
From
North America Neurology Devices Market - Growth, Trends, and Forecasts (2023-2028) - Product Image

North America Neurology Devices Market - Growth, Trends, and Forecasts (2023-2028)

  • Report
  • 71 Pages
  • North America
From
Neurology Devices Market by Product, End User - Global Forecast 2025-2030 - Product Image

Neurology Devices Market by Product, End User - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Neurology Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Neurology Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 116 Pages
  • Global
From
Neurology Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Neurology Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.